The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Histone Deacetylase Inhibitors-Global Market Insights and Sales Trends 2025
Synopsis
Histone Deacetylase Inhibitors Product Introduction Histone deacetylase inhibitors (HDAC inhibitors, HDACi, HDIs) are chemical compounds that inhibit histone deacetylases.
The global Histone Deacetylase Inhibitors market size is expected to reach US$ 2291 million by 2029, growing at a CAGR of 12.1% from 2023 to 2029. The market is mainly driven by the significant applications of Histone Deacetylase Inhibitors in various end use industries. The expanding demands from the Cancer Treatment, Inflammatory Diseases and Other Diseases,, are propelling Histone Deacetylase Inhibitors market. Belinostat, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Romidepsin segment is estimated at % CAGR for the next seven-year period.
HDIs have a long history of use in psychiatry and neurology as mood stabilizers and anti-epileptics. More recently they are being investigated as possible treatments for cancers, parasitic and inflammatory diseases…
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Histone Deacetylase Inhibitors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Histone Deacetylase Inhibitors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Histone Deacetylase Inhibitors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Histone Deacetylase Inhibitors sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Histone Deacetylase Inhibitors covered in this report include Merck, Celgene, Teva Pharms, Acrotech and Spectrum Pharmaceuticals, etc.
The global Histone Deacetylase Inhibitors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Celgene
Teva Pharms
Acrotech
Spectrum Pharmaceuticals
Global Histone Deacetylase Inhibitors market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Histone Deacetylase Inhibitors market, Segment by Type:
Belinostat
Romidepsin
Chidamide
Global Histone Deacetylase Inhibitors market, by Application
Cancer Treatment
Inflammatory Diseases
Other Diseases
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Histone Deacetylase Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Histone Deacetylase Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Histone Deacetylase Inhibitors Product Introduction Histone deacetylase inhibitors (HDAC inhibitors, HDACi, HDIs) are chemical compounds that inhibit histone deacetylases.
The global Histone Deacetylase Inhibitors market size is expected to reach US$ 2291 million by 2029, growing at a CAGR of 12.1% from 2023 to 2029. The market is mainly driven by the significant applications of Histone Deacetylase Inhibitors in various end use industries. The expanding demands from the Cancer Treatment, Inflammatory Diseases and Other Diseases,, are propelling Histone Deacetylase Inhibitors market. Belinostat, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Romidepsin segment is estimated at % CAGR for the next seven-year period.
HDIs have a long history of use in psychiatry and neurology as mood stabilizers and anti-epileptics. More recently they are being investigated as possible treatments for cancers, parasitic and inflammatory diseases…
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Histone Deacetylase Inhibitors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Histone Deacetylase Inhibitors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Histone Deacetylase Inhibitors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Histone Deacetylase Inhibitors sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Histone Deacetylase Inhibitors covered in this report include Merck, Celgene, Teva Pharms, Acrotech and Spectrum Pharmaceuticals, etc.
The global Histone Deacetylase Inhibitors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Celgene
Teva Pharms
Acrotech
Spectrum Pharmaceuticals
Global Histone Deacetylase Inhibitors market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Histone Deacetylase Inhibitors market, Segment by Type:
Belinostat
Romidepsin
Chidamide
Global Histone Deacetylase Inhibitors market, by Application
Cancer Treatment
Inflammatory Diseases
Other Diseases
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Histone Deacetylase Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Histone Deacetylase Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Histone Deacetylase Inhibitors Market Overview
1.1 Histone Deacetylase Inhibitors Product Overview
1.2 Histone Deacetylase Inhibitors Market Segment by Type
1.2.1 Belinostat
1.2.2 Romidepsin
1.2.3 Chidamide
1.3 Global Histone Deacetylase Inhibitors Market Size by Type
1.3.1 Global Histone Deacetylase Inhibitors Market Size Overview by Type (2018-2029)
1.3.2 Global Histone Deacetylase Inhibitors Historic Market Size Review by Type (2018-2023)
1.3.3 Global Histone Deacetylase Inhibitors Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Histone Deacetylase Inhibitors Sales Breakdown by Type (2018-2023)
1.4.2 Europe Histone Deacetylase Inhibitors Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Histone Deacetylase Inhibitors Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Histone Deacetylase Inhibitors Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Histone Deacetylase Inhibitors Sales Breakdown by Type (2018-2023)
2 Global Histone Deacetylase Inhibitors Market Competition by Company
2.1 Global Top Players by Histone Deacetylase Inhibitors Sales (2018-2023)
2.2 Global Top Players by Histone Deacetylase Inhibitors Revenue (2018-2023)
2.3 Global Top Players by Histone Deacetylase Inhibitors Price (2018-2023)
2.4 Global Top Manufacturers Histone Deacetylase Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Histone Deacetylase Inhibitors Market Competitive Situation and Trends
2.5.1 Histone Deacetylase Inhibitors Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Histone Deacetylase Inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Histone Deacetylase Inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into Histone Deacetylase Inhibitors Market
2.8 Key Manufacturers Histone Deacetylase Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Histone Deacetylase Inhibitors Status and Outlook by Region
3.1 Global Histone Deacetylase Inhibitors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Histone Deacetylase Inhibitors Historic Market Size by Region
3.2.1 Global Histone Deacetylase Inhibitors Sales in Volume by Region (2018-2023)
3.2.2 Global Histone Deacetylase Inhibitors Sales in Value by Region (2018-2023)
3.2.3 Global Histone Deacetylase Inhibitors Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Histone Deacetylase Inhibitors Forecasted Market Size by Region
3.3.1 Global Histone Deacetylase Inhibitors Sales in Volume by Region (2024-2029)
3.3.2 Global Histone Deacetylase Inhibitors Sales in Value by Region (2024-2029)
3.3.3 Global Histone Deacetylase Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Histone Deacetylase Inhibitors by Application
4.1 Histone Deacetylase Inhibitors Market Segment by Application
4.1.1 Cancer Treatment
4.1.2 Inflammatory Diseases
4.1.3 Other Diseases
4.2 Global Histone Deacetylase Inhibitors Market Size by Application
4.2.1 Global Histone Deacetylase Inhibitors Market Size Overview by Application (2018-2029)
4.2.2 Global Histone Deacetylase Inhibitors Historic Market Size Review by Application (2018-2023)
4.2.3 Global Histone Deacetylase Inhibitors Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Histone Deacetylase Inhibitors Sales Breakdown by Application (2018-2023)
4.3.2 Europe Histone Deacetylase Inhibitors Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Histone Deacetylase Inhibitors Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Histone Deacetylase Inhibitors Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Histone Deacetylase Inhibitors Sales Breakdown by Application (2018-2023)
5 North America Histone Deacetylase Inhibitors by Country
5.1 North America Histone Deacetylase Inhibitors Historic Market Size by Country
5.1.1 North America Histone Deacetylase Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Histone Deacetylase Inhibitors Sales in Volume by Country (2018-2023)
5.1.3 North America Histone Deacetylase Inhibitors Sales in Value by Country (2018-2023)
5.2 North America Histone Deacetylase Inhibitors Forecasted Market Size by Country
5.2.1 North America Histone Deacetylase Inhibitors Sales in Volume by Country (2024-2029)
5.2.2 North America Histone Deacetylase Inhibitors Sales in Value by Country (2024-2029)
6 Europe Histone Deacetylase Inhibitors by Country
6.1 Europe Histone Deacetylase Inhibitors Historic Market Size by Country
6.1.1 Europe Histone Deacetylase Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Histone Deacetylase Inhibitors Sales in Volume by Country (2018-2023)
6.1.3 Europe Histone Deacetylase Inhibitors Sales in Value by Country (2018-2023)
6.2 Europe Histone Deacetylase Inhibitors Forecasted Market Size by Country
6.2.1 Europe Histone Deacetylase Inhibitors Sales in Volume by Country (2024-2029)
6.2.2 Europe Histone Deacetylase Inhibitors Sales in Value by Country (2024-2029)
7 Asia-Pacific Histone Deacetylase Inhibitors by Region
7.1 Asia-Pacific Histone Deacetylase Inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific Histone Deacetylase Inhibitors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Histone Deacetylase Inhibitors Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Histone Deacetylase Inhibitors Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Histone Deacetylase Inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific Histone Deacetylase Inhibitors Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Histone Deacetylase Inhibitors Sales in Value by Region (2024-2029)
8 Latin America Histone Deacetylase Inhibitors by Country
8.1 Latin America Histone Deacetylase Inhibitors Historic Market Size by Country
8.1.1 Latin America Histone Deacetylase Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Histone Deacetylase Inhibitors Sales in Volume by Country (2018-2023)
8.1.3 Latin America Histone Deacetylase Inhibitors Sales in Value by Country (2018-2023)
8.2 Latin America Histone Deacetylase Inhibitors Forecasted Market Size by Country
8.2.1 Latin America Histone Deacetylase Inhibitors Sales in Volume by Country (2024-2029)
8.2.2 Latin America Histone Deacetylase Inhibitors Sales in Value by Country (2024-2029)
9 Middle East and Africa Histone Deacetylase Inhibitors by Country
9.1 Middle East and Africa Histone Deacetylase Inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa Histone Deacetylase Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Histone Deacetylase Inhibitors Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Histone Deacetylase Inhibitors Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Histone Deacetylase Inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa Histone Deacetylase Inhibitors Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Histone Deacetylase Inhibitors Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Histone Deacetylase Inhibitors Products Offered
10.1.5 Merck Recent Development
10.2 Celgene
10.2.1 Celgene Company Information
10.2.2 Celgene Introduction and Business Overview
10.2.3 Celgene Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Celgene Histone Deacetylase Inhibitors Products Offered
10.2.5 Celgene Recent Development
10.3 Teva Pharms
10.3.1 Teva Pharms Company Information
10.3.2 Teva Pharms Introduction and Business Overview
10.3.3 Teva Pharms Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Teva Pharms Histone Deacetylase Inhibitors Products Offered
10.3.5 Teva Pharms Recent Development
10.4 Acrotech
10.4.1 Acrotech Company Information
10.4.2 Acrotech Introduction and Business Overview
10.4.3 Acrotech Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Acrotech Histone Deacetylase Inhibitors Products Offered
10.4.5 Acrotech Recent Development
10.5 Spectrum Pharmaceuticals
10.5.1 Spectrum Pharmaceuticals Company Information
10.5.2 Spectrum Pharmaceuticals Introduction and Business Overview
10.5.3 Spectrum Pharmaceuticals Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Spectrum Pharmaceuticals Histone Deacetylase Inhibitors Products Offered
10.5.5 Spectrum Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Histone Deacetylase Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Histone Deacetylase Inhibitors Industrial Chain Analysis
11.4 Histone Deacetylase Inhibitors Market Dynamics
11.4.1 Histone Deacetylase Inhibitors Industry Trends
11.4.2 Histone Deacetylase Inhibitors Market Drivers
11.4.3 Histone Deacetylase Inhibitors Market Challenges
11.4.4 Histone Deacetylase Inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Histone Deacetylase Inhibitors Distributors
12.3 Histone Deacetylase Inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
